Pharmaceutical business to create jobs after landing £250,000 loan

A Whetstone-based pharmaceutical business has secured a £250,000 loan to support the development of its latest software platform and enable it to create seven jobs.

Remedi Pharmacy Solutions secured the finance from the Midlands Engine Investment Fund (MEIF), provided by The FSE Group Debt Finance Fund and backed by the Coronavirus Business Interruption Loan Scheme (CBILS).

The new roles will allow Remedi to strengthen its sales and distributions teams, reach out to more customers and cover a wider geographical area, helping the business to achieve its expansion plans.

Remedi is a pharmaceutical distribution business that provides direct to door prescription fulfilment.

The funding will be used alongside external finance to further develop and roll-out the company’s proprietary software which will see it move to a fully automated, electronic dispensing process.

Remedi also delivers its services to care homes, using a software system to provide both medicine management and care planning.

Kenny Black, managing director of Remedi Pharmacy Solutions, said: “The electronic processing of prescriptions, combined with direct delivery, has had a positive impact on care homes in these challenging Covid-19 times. As the business expands, this loan will allow us to create new positions to service the increase in demand and continue to deliver to more care homes. Thanks to The FSE Group for guiding us through the funding process, enabling us to secure the funds to support our growth ambitions.”